Evidence map›Paper›PMID 24337239›Full record

Trial reportDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete2014

[Cutaneous leishmaniasis. Diagnosis and therapy in northern Afghanistan].

R Dieterle, H Pillekamp

Abstract readClinical TrialEnglish Abstract
PubMed Publisher
In one paragraph

Trial report in Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. [Epidemiology and prevention of leishmaniasis in northern Afghanistan].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

R DieterleFachsanitätszentrum Leipzig , Kornblumenweg 4, 04158, Leipzig, Deutschland, Rolf.Dieterle@t-online.de.
H Pillekamp

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe German S1 guidelines from 2009 contain a variety of recommendations for the treatment of cutaneous leishmaniasis. PATIENTS AND

methodsWe report the results of our diagnostic procedures and treatment of 32 international patients in autumn 2010 in northern Afghanistan.

resultsGiemsa stain confirmed the clinical diagnosis within 24 hours. Eleven simple lesions and one larger ulcer responded well to cryotherapy and intralesional sodium stibogluconate. More complex lesions in 19 patients responded well to oral miltefosine. One patient refused outpatient therapy.

conclusionsCryotherapy and intralesional antimony compounds showed good results in early lesions of cutaneous leishmaniasis in northern Afghanistan. Outpatient treatment of complex lesions with miltefosine was successful in all cases.

Indexed as

Administration, TopicalAdultAfghanistanAntimony Sodium GluconateAntiprotozoal AgentsCombined Modality TherapyCryotherapyDermatologic AgentsHumansInternationalityLeishmaniasis, CutaneousMaleMilitary PersonnelPhosphorylcholineTreatment OutcomeYoung AdultAntimony Sodium GluconateAntiprotozoal AgentsDermatologic AgentsmiltefosinePhosphorylcholine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.